03/18/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
7:06 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
6:55 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
7:07 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4/A | |
01/24/2025
7:09 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4/A | |
01/24/2025
7:10 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4/A | |
Get the Latest News and Ratings for ALLR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/24/2025
3:12 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:13 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:14 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:16 PM | Allarity Therapeutics (Issuer)
Jensen Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:17 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:18 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:24 PM | 3i, LP (Filed by)
Allarity Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:32 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:34 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:05 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
7:53 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 8-K/A | |
09/09/2024
8:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
4:57 PM | Allarity Therapeutics (Subject)
Olmsted Investments LLC (Filed by)
| Form SCHEDULE 13G | |
08/21/2024
3:55 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
4:24 PM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
5:04 AM | Allarity Therapeutics (Filer)
| Form DEFA14A | |
07/23/2024
3:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
5:03 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
3:47 PM | Allarity Therapeutics (Filer)
| Form DEF 14A | |
07/01/2024
3:47 PM | Allarity Therapeutics (Filer)
| Form ARS | |
06/28/2024
7:45 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:45 PM | Allarity Therapeutics (Filer)
| Form PRE 14A | |
DOGE tax surprise (Ad) Elon Musk's DOGE agents have some very strange plans for the IRS...
Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars.
It's the most advanced technology offered by AI giant Nvidia.
And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government. Move now and you could get in first - with huge upside potential. |
06/21/2024
3:30 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:54 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:55 AM | Allarity Therapeutics (Filer)
| Form 8-K/A | |
05/21/2024
7:15 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:45 PM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
10:21 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
05/09/2024
8:47 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
8:29 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
8:13 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
05/03/2024
5:09 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
9:56 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
05/02/2024
8:42 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
05/02/2024
7:14 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/30/2024
7:10 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
6:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
8:17 AM | Allarity Therapeutics (Filer)
| Form S-1/A | |
04/15/2024
7:30 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/12/2024
1:10 PM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/11/2024
12:30 PM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/09/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/05/2024
7:30 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
7:30 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:01 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ALLR Stock Free ALLR Stock Alerts